Lessons Learned: Next-generation Sequencing Applied to Undiagnosed Genetic Diseases

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2022 Apr 1

PMID 35362483

Authors

Bryce A Schuler

Erica T Nelson

Mary Koziura

Joy D Cogan

Rizwan Hamid

John A Phillips 3rd

Affiliations

Soon will be listed here.

Abstract

Rare genetic disorders, when considered together, are relatively common. Despite advancements in genetics and genomics technologies as well as increased understanding of genomic function and dysfunction, many genetic diseases continue to be difficult to diagnose. The goal of this Review is to increase the familiarity of genetic testing strategies for non-genetics providers. As genetic testing is increasingly used in primary care, many subspecialty clinics, and various inpatient settings, it is important that non-genetics providers have a fundamental understanding of the strengths and weaknesses of various genetic testing strategies as well as develop an ability to interpret genetic testing results. We provide background on commonly used genetic testing approaches, give examples of phenotypes in which the various genetic testing approaches are used, describe types of genetic and genomic variations, cover challenges in variant identification, provide examples in which next-generation sequencing (NGS) failed to uncover the variant responsible for a disease, and discuss opportunities for continued improvement in the application of NGS clinically. As genetic testing becomes increasingly a part of all areas of medicine, familiarity with genetic testing approaches and result interpretation is vital to decrease the burden of undiagnosed disease.

Citing Articles

Fetal genetic factors in pregnancy loss: Insights from a meta-analysis and effectiveness of whole exome sequencing.

Hadjipanteli A, Theodosiou A, Papaevripidou I, Alexandrou A, Salameh N, Evangelidou P PLoS One. 2025; 20(2):e0319052.

PMID: 39999070 PMC: 11856309. DOI: 10.1371/journal.pone.0319052.

Phenotypic and molecular characterization of the largest worldwide cluster of hereditary angioedema type 1.

Arias-Florez J, Ramirez S, Bayona-Gomez B, Castro-Castillo L, Correa-Martinez V, Sanchez-Gomez Y PLoS One. 2024; 19(12):e0311316.

PMID: 39724085 PMC: 11671010. DOI: 10.1371/journal.pone.0311316.

A review of multiple diagnostic approaches in the undiagnosed diseases network to identify inherited metabolic diseases.

Furuta Y, Tinker R, Hamid R, Cogan J, Ezell K, Oglesbee D Orphanet J Rare Dis. 2024; 19(1):427.

PMID: 39543639 PMC: 11566889. DOI: 10.1186/s13023-024-03423-3.

Coexistence of adeno-associated virus 2 with adenovirus 18 or herpesvirus may be associated with severe lingual papillomatosis in an immunocompromised individual.

Yu J, Liang Z, Fu Y, Peng X, Zheng Y, Dong Y Virol Sin. 2024; 39(4):705-707.

PMID: 38914259 PMC: 11401458. DOI: 10.1016/j.virs.2024.06.006.

Evaluating the utility of multi-gene, multi-disease population-based panel testing accounting for uncertainty in penetrance estimates.

Liang J, Christensen K, Green R, Kraft P NPJ Genom Med. 2024; 9(1):30.

PMID: 38760335 PMC: 11101660. DOI: 10.1038/s41525-024-00414-y.

References

Palmer E, Schofield D, Shrestha R, Kandula T, Macintosh R, Lawson J . Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness. Mol Genet Genomic Med. 2018; 6(2):186-199. PMC: 5902395. DOI: 10.1002/mgg3.355. View

Dimmock D, Clark M, Gaughran M, Cakici J, Caylor S, Clarke C . An RCT of Rapid Genomic Sequencing among Seriously Ill Infants Results in High Clinical Utility, Changes in Management, and Low Perceived Harm. Am J Hum Genet. 2020; 107(5):942-952. PMC: 7675004. DOI: 10.1016/j.ajhg.2020.10.003. View

Liu Z, Zhu L, Roberts R, Tong W . Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?. Trends Genet. 2019; 35(11):852-867. DOI: 10.1016/j.tig.2019.08.006. View

Yang Y, Muzny D, Reid J, Bainbridge M, Willis A, Ward P . Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013; 369(16):1502-11. PMC: 4211433. DOI: 10.1056/NEJMoa1306555. View

Denny J, Rutter J, Goldstein D, Philippakis A, Smoller J, Jenkins G . The "All of Us" Research Program. N Engl J Med. 2019; 381(7):668-676. PMC: 8291101. DOI: 10.1056/NEJMsr1809937. View

Lionel A, Costain G, Monfared N, Walker S, Reuter M, Hosseini S . Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med. 2017; 20(4):435-443. PMC: 5895460. DOI: 10.1038/gim.2017.119. View

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

Gonzales P, Carroll A, Korf B . Overview of Clinical Cytogenetics. Curr Protoc Hum Genet. 2016; 89:8.1.1-8.1.13. DOI: 10.1002/0471142905.hg0801s89. View

Ghosh A, Schlecht H, Heptinstall L, Bassett J, Cartwright E, Bhaskar S . Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing. Arch Dis Child. 2017; 102(11):1019-1029. DOI: 10.1136/archdischild-2017-312738. View

10.

Farwell K, Shahmirzadi L, El-Khechen D, Powis Z, Chao E, Davis B . Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med. 2014; 17(7):578-86. DOI: 10.1038/gim.2014.154. View

11.

Grant P, Langlois S, Lynd L, Austin J, Elliott A . Out-of-pocket and private pay in clinical genetic testing: A scoping review. Clin Genet. 2021; 100(5):504-521. DOI: 10.1111/cge.14006. View

12.

Logsdon G, Vollger M, Eichler E . Long-read human genome sequencing and its applications. Nat Rev Genet. 2020; 21(10):597-614. PMC: 7877196. DOI: 10.1038/s41576-020-0236-x. View

13.

Rafehi H, Szmulewicz D, Bennett M, Sobreira N, Pope K, Smith K . Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS. Am J Hum Genet. 2019; 105(1):151-165. PMC: 6612533. DOI: 10.1016/j.ajhg.2019.05.016. View

14.

Boxer A, Mackenzie I, Boeve B, Baker M, Seeley W, Crook R . Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry. 2010; 82(2):196-203. PMC: 3017222. DOI: 10.1136/jnnp.2009.204081. View

15.

Zemojtel T, Kohler S, Mackenroth L, Jager M, Hecht J, Krawitz P . Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci Transl Med. 2014; 6(252):252ra123. PMC: 4512639. DOI: 10.1126/scitranslmed.3009262. View

16.

Zhong A, Darren B, Dimaras H . Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: protocol for a systematic review. Syst Rev. 2017; 6(1):140. PMC: 5505010. DOI: 10.1186/s13643-017-0535-2. View

17.

. Newborn screening: toward a uniform screening panel and system--executive summary. Pediatrics. 2006; 117(5 Pt 2):S296-307. DOI: 10.1542/peds.2005-2633I. View

18.

Manning M, Hudgins L . Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010; 12(11):742-5. PMC: 3111046. DOI: 10.1097/GIM.0b013e3181f8baad. View

19.

Sedlazeck F, Rescheneder P, Smolka M, Fang H, Nattestad M, von Haeseler A . Accurate detection of complex structural variations using single-molecule sequencing. Nat Methods. 2018; 15(6):461-468. PMC: 5990442. DOI: 10.1038/s41592-018-0001-7. View

20.

Paul J, Leslie H, Trainer A, Gaff C . A theory-informed systematic review of clinicians' genetic testing practices. Eur J Hum Genet. 2018; 26(10):1401-1416. PMC: 6138746. DOI: 10.1038/s41431-018-0190-7. View